You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML in first remission, first relapse or subsequent remission

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Rituximab, Methotrexate, Temozolomide
  • Paris, France
    Groupe Hospitalier Pitie Salpetriere
Feb 10, 2022

Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Loma Linda, California
  • +36 more
Feb 1, 2023

Bipolar Affective Disorder Trial in Moscow (Quetiapine)

Recruiting
  • Bipolar Affective Disorder
  • Moscow, Russian Federation
    Mental health research center
Oct 18, 2021

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose

Active, not recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Beijing, China
  • +47 more
Aug 17, 2022

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
Jan 9, 2023

Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • La Jolla, California
  • +8 more
Jan 31, 2023

Acute Myeloid Leukemia Trial in United States (SL-401)

Terminated
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +6 more
Jan 13, 2022

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Microfluidic Assay to Detect Minimal Residual Disease and

Completed
  • Acute Myeloid Leukemia
    • Chapel Hill, North Carolina
      UNC Lineberger
    Jan 12, 2021

    AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

    Recruiting
    • AML
    • MDS
    • Tuebingen, Baden-Wuerttemberg, Germany
      University Hospital
    Nov 30, 2023

    Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Atlanta, Georgia
    • +1 more
    Oct 26, 2021

    Acute Myeloid Leukaemia Trial (SAR445419, fludarabine, cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukaemia
    • (no location specified)
    Feb 2, 2023

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    Leukemia, Myeloid, Acute Trial in Germany (Human Stem Cell Transplantation, Consolidation chemo, i.e. High-dose Cytarabine

    Terminated
    • Leukemia, Myeloid, Acute
    • Human Stem Cell Transplantation
    • Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
    • Aachen, Germany
    • +18 more
    Oct 28, 2021

    Limited Stage Small Cell Lung Cancer Trial in Jinan (MRI Surveillance, Prophylactic Cranial Irradiation)

    Recruiting
    • Limited Stage Small Cell Lung Cancer
    • MRI Surveillance
    • Prophylactic Cranial Irradiation
    • Jinan, Shandong, China
    • +1 more
    Apr 28, 2021

    AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

    Recruiting
    • AML/MDS
    • +5 more
    • Ann Arbor, Michigan
    • +7 more
    Feb 14, 2022

    Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

    Active, not recruiting
    Has Results
    • Myelodysplastic Syndrome
    • +2 more
    • Daphne, Alabama
    • +241 more
    Dec 23, 2022

    Platelet Transfusion Refractoriness, Acute Leukemia in Remission Trial in Suzhou (CAR-T infusion)

    Recruiting
    • Platelet Transfusion Refractoriness
    • Acute Leukemia in Remission
    • CAR-T infusion
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Oct 19, 2021

    Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

    Recruiting
    • Myeloid Malignancies
    • Magrolimab
    • +6 more
    • Birmingham, Alabama
    • +12 more
    Apr 6, 2022

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    Venetoclax Plasma Concentration and Remission in Acute Myeloid

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • Blood sampling for venetoclax drug dosage (venous puncture)
    • (no location specified)
    Sep 13, 2023

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

    Not yet recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • (no location specified)
    May 24, 2023

    MDD, Remission Trial in Shanghai (treatment as usual)

    Recruiting
    • Major Depressive Disorder
    • Remission
    • treatment as usual
    • Shanghai, China
      Shanghai Mental Health Center
    Jul 22, 2021

    Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Decitabine,

    Unknown status
    • Acute Myeloid Leukemia
    • +3 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Dec 18, 2020